
OSE Immunotherapeutics SA
PAR:OSE

OSE Immunotherapeutics SA
Total Other Income
OSE Immunotherapeutics SA
Total Other Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
OSE Immunotherapeutics SA
PAR:OSE
|
Total Other Income
€1.4m
|
CAGR 3-Years
392%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Valneva SE
PAR:VLA
|
Total Other Income
-€4k
|
CAGR 3-Years
76%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Nanobiotix SA
PAR:NANO
|
Total Other Income
€1k
|
CAGR 3-Years
-71%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
G
|
Genfit SA
PAR:GNFT
|
Total Other Income
€891k
|
CAGR 3-Years
103%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
![]() |
Inventiva SA
PAR:IVA
|
Total Other Income
€6.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
150%
|
CAGR 10-Years
N/A
|
|
![]() |
Eurobio Scientific SA
PAR:ALERS
|
Total Other Income
€1.9m
|
CAGR 3-Years
95%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
58%
|
OSE Immunotherapeutics SA
Glance View
OSE Immunotherapeutics SA develops immunotherapy products for cancer and auto-immune disease. The company is headquartered in Nantes, Pays De La Loire and currently employs 61 full-time employees. The company went IPO on 2015-03-30. The company develops immunotherapies, directly or through partnerships, for the activation and regulation of the immune system in immuno-oncology and in autoimmune diseases. The firm's research and development in immunology is based on 3 platforms, such as T cell-based vaccines, Immuno-Oncology (myeloid targets) and Auto-Immunity & Inflammation. The company provides technological and scientific platforms: neoepitopes, agonist or antagonist monoclonal antibodies, ideally positioned to fight cancer and autoimmune diseases.

See Also
What is OSE Immunotherapeutics SA's Total Other Income?
Total Other Income
1.4m
EUR
Based on the financial report for Jun 30, 2024, OSE Immunotherapeutics SA's Total Other Income amounts to 1.4m EUR.
What is OSE Immunotherapeutics SA's Total Other Income growth rate?
Total Other Income CAGR 3Y
392%
Over the last year, the Total Other Income growth was 2 760%. The average annual Total Other Income growth rates for OSE Immunotherapeutics SA have been 392% over the past three years .